Evaluation of various hypotensive agents in the control of experimental hemorrhage.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002746:Chlorpromazine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006145:Guanethidine / Q000627:therapeutic use; D006470:Hemorrhage / Q000517:prevention & control*; D006830:Hydralazine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011526:Protoveratrines / Q000627:therapeutic use; D014043:Tolazoline / Q000627:therapeutic use
D000959:Antihypertensive Agents; D011526:Protoveratrines; D010643:Phenoxybenzamine; D006830:Hydralazine; D014043:Tolazoline; D003981:Diazoxide; D002746:Chlorpromazine; D006145:Guanethidine